Literature DB >> 33830359

Early Recurrence Following Resection of Distal Cholangiocarcinoma: A New Tool for the Toolbox.

Bradley N Reames1, Flavio G Rocha2.   

Abstract

Entities:  

Year:  2021        PMID： 33830359     DOI： 10.1245/s10434-021-09961-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  ASO Author Reflections: Development and Validation of Distal Cholangiocarcinoma Early Recurrence (DICER) Score: Results from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Kota Sahara; Diamantis I Tsilimigras; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-03-21       Impact factor: 5.344

2.  Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.

Authors:  Robert W Krell; Logan R McNeil; Ujwal R Yanala; Chandrakanth Are; Bradley N Reames
Journal:  Ann Surg Oncol       Date:  2021-01-01       Impact factor: 5.344

3.  Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).

Authors:  Jelle C van Dongen; Mustafa Suker; Eva Versteijne; Bert A Bonsing; J Sven D Mieog; Judith de Vos-Geelen; Erwin van der Harst; Gijs A Patijn; Ignace H de Hingh; Sebastiaan Festen; Albert J Ten Tije; Olivier R Busch; Marc G Besselink; Geertjan van Tienhoven; Bas Groot Koerkamp; Casper H J van Eijck
Journal:  Ann Surg       Date:  2020-11-12       Impact factor: 12.969
  3 in total
  2 in total

1.  Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.

Authors:  Hongguang Li; Lingxin Qu; Yongheng Yang; Haibin Zhang; Xuexin Li; Xiaolu Zhang
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-24

Review 2.  Surgical Treatment of Distal Cholangiocarcinoma.

Authors:  Leva Gorji; Eliza W Beal
Journal:  Curr Oncol       Date:  2022-09-17       Impact factor: 3.109
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.